Literature DB >> 6179534

Combination therapy for dendritic keratitis with human leucocyte interferon and trifluorothymidine.

E W de Koning, O P van Bijsterveld, K Cantell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6179534      PMCID： PMC1039837          DOI： 10.1136/bjo.66.8.509

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  9 in total

Review 1.  Prospects for the clinical use of exogenous interferon.

Authors:  K Cantell
Journal:  Med Biol       Date:  1977-04

2.  Optimal schedules for use of interferon in the corneas of rabbits with herpes simplex keratitis.

Authors:  J I McGill; P Collins; K Cantell; B R Jones; N B Finter
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

3.  Long-term poly I:C in experimental chronic ocular herpes simplex infection.

Authors:  A B Nesburn; P J Ziniti
Journal:  Am J Ophthalmol       Date:  1971-10       Impact factor: 5.258

4.  Interferon induction in rabbit and human tears.

Authors:  Y M Centifanto; R M Goorha; H E Kaufman
Journal:  Am J Ophthalmol       Date:  1970-12       Impact factor: 5.258

5.  Combination therapy of dendritic keratitis with trifluorothymidine and interferon.

Authors:  R Sundmacher; K Cantell; D Neumann-Haefelin
Journal:  Lancet       Date:  1978-09-23       Impact factor: 79.321

6.  Human leukocyte interferon for the prevention of recurrences of herpetic keratitis.

Authors:  H E Kaufman; R F Meyer; P R Laibson; S R Waltman; A B Nesburn; J J Shuster
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

7.  Topical therapy of ulcerative herpetic keratitis with human interferon.

Authors:  B R Jones; D J Coster; M G Falcon; K Cantell
Journal:  Lancet       Date:  1976-07-17       Impact factor: 79.321

8.  Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis.

Authors:  H KAUFMAN; E L MARTOLA; C DOHLMAN
Journal:  Arch Ophthalmol       Date:  1962-08

9.  Trifluorothymidine versus adenine arabinoside in the treatment of herpes simplex keratitis.

Authors:  O P Van Bijsterveld; H Post
Journal:  Br J Ophthalmol       Date:  1980-01       Impact factor: 4.638
  9 in total
  7 in total

Review 1.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2015-01-09

2.  Recombinant HuIFN-gamma prevents herpes simplex keratitis in African green monkeys: demonstration of synergism with recombinant HuIFN-alpha 2.

Authors:  D Neumann-Haefelin; R Sundmacher; H Frey; W Merk
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

3.  Therapy of genital herpes with topically applied interferon.

Authors:  L J Eron; C Toy; B Salsitz; R R Scheer; D L Wood; P I Nadler
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

4.  Nucleoside metabolism in herpes simplex virus-infected cells following treatment with interferon and acyclovir, a possible mechanism of synergistic antiviral activity.

Authors:  W J O'Brien; E C Coe; J L Taylor
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  Biosynthetic human interferon treatment of herpetic keratitis.

Authors:  G Smolin
Journal:  Trans Am Ophthalmol Soc       Date:  1983

6.  The treatment of herpes simplex virus epithelial keratitis.

Authors:  K R Wilhelmus
Journal:  Trans Am Ophthalmol Soc       Date:  2000

Review 7.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.